Chetan Pujara, Ph.D Chief Research & Development Officer, SpyGlass Pharma Dr. Pujara brings extensive industry experience to guide late-stage development…
COPENHAGEN, Denmark, March 27, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™…
BOULDER, Colo., March 26, 2025 /PRNewswire/ -- Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced…
SAN FRANCISCO, March 26, 2025 /PRNewswire/ -- Medrio, a global leader in clinical trial technology, today announced enhancements to its randomization…
NEW YORK and PARIS, March 26, 2025 /PRNewswire/ -- Rarecells Inc., a pioneering company in liquid biopsy technology, is pleased…
New tools will calculate the ROI of using digital endpoints in clinical trials, empowering greater innovation in research BOSTON, March…
Preclinical Data to Support Advancement Toward First-in-Human Clinical Trials SARASOTA, FL, March 26, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc.…
AZURE-1 will evaluate the efficacy and safety of brelovitug compared to delayed treatmentREDWOOD CITY, Calif., March 26, 2025 (GLOBE NEWSWIRE)…
PHILADELPHIA and VANCOUVER, British Columbia, March 26, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell”…
SOUTH SAN FRANCISCO, Calif., March 26, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical…